We're Hopeful That 4D Molecular Therapeutics (NASDAQ:FDMT) Will Use Its Cash Wisely

Yahoo FinanceOct 30 22:26

4D Molecular Therapeutics Downgraded at Cantor Following Wet AMD Asset Data

Seeking AlphaSep 24 01:41 · Ratings

4D Molecular Therapeutics Analyst Ratings

BenzingaSep 24 00:55 · Ratings

4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference

GlobeNewswireSep 23 20:00

Cantor Fitzgerald Downgrades 4D Molecular Therapeutics(FDMT.US) to Hold Rating

Cantor Fitzgerald analyst Joshua Schimmer downgrades $4D Molecular Therapeutics(FDMT.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 52.2% and a total average

Futu NewsSep 23 19:31 · Ratings

Cantor Fitzgerald Downgrades 4D Molecular Therapeutics to Neutral From Overweight

MT NewswiresSep 23 19:16